MicroRNAs in Pediatric Acute Lymphoblastic Leukemia: Small players with huge potential

作者: Diana Schotte

DOI:

关键词:

摘要: textabstractHematopoiesis is a dynamic balance of cellular proliferation, survival, apoptosis and differentiation in which the pluripotent hematopoietic stem cell gives rise to lymphoid and myeloid precursors blood cells. The B-lymphoid precursor sequentially differentiates from proB-cells into common/preB-cells and fi nally yields mature B-lymphocytes. T-lymphoid precursor generates thymocytes or proT-cells that further differentiate T-lymphocytes. The myeloid granulocytes, monocytes, platelets erythrocytes. This process under tight surveillance by regulators including transcription factors, cytokines and growth factors. In case defects and/or oncogenic hits maturing hematopoietic cell, cells may arrest at different levels maturation. Leukemia grow exponentially with limited differentiation thereby suppressing development normal blood bone marrow. As consequence leukemia patients suffer from fatigue (shortage erythrocytes anemia), infections (shortage lymphocytes and granulocytes) bleeding (low platelet numbers). Despite fact multiple consecutive events are required for leukemia, clinical symptoms associated with acute occur rather abrupt progression disease very fast if not treated instantly.

参考文章(240)
Ching-Hon Pui, William E. Evans, Treatment of Acute Lymphoblastic Leukemia New England Journal of Medicine. ,vol. 354, pp. 166- 178 ,(2006) , 10.1056/NEJMRA052603
Ron Edgar, Michael Domrachev, Alex E Lash, Gene Expression Omnibus: NCBI gene expression and hybridization array data repository Nucleic Acids Research. ,vol. 30, pp. 207- 210 ,(2002) , 10.1093/NAR/30.1.207
R. Pieters, D.R. Huismans, A.H. Loonen, A.J.P. Veerman, K. Hahlen, A. van der Does-van den Berg, E.R. Wering, Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia The Lancet. ,vol. 338, pp. 399- 403 ,(1991) , 10.1016/0140-6736(91)91029-T
Robin C Friedman, Kyle Kai-How Farh, Christopher B Burge, David P Bartel, Most mammalian mRNAs are conserved targets of microRNAs Genome Research. ,vol. 19, pp. 92- 105 ,(2008) , 10.1101/GR.082701.108
Barbara Weber, Carlo Stresemann, Bodo Brueckner, Frank Lyko, Methylation of human microRNA genes in normal and neoplastic cells Cell Cycle. ,vol. 6, pp. 1001- 1005 ,(2007) , 10.4161/CC.6.9.4209
Yoshimasa Saito, Gangning Liang, Gerda Egger, Jeffrey M. Friedman, Jody C. Chuang, Gerhard A. Coetzee, Peter A. Jones, Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells Cancer Cell. ,vol. 9, pp. 435- 443 ,(2006) , 10.1016/J.CCR.2006.04.020
Maurizio Aricò, Maria Grazia Valsecchi, Bruce Camitta, Martin Schrappe, Judith Chessells, André Baruchel, Paul Gaynon, Lewis Silverman, Gritta Janka-Schaub, Willem Kamps, Ching-Hon Pui, V. Conter, H. Riehm, N. Heerema, S. Sallan, J. Pullen, J. Shuster, A. Carroll, S. Raimondi, S. Richards, Giuseppe Masera, Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia The New England Journal of Medicine. ,vol. 342, pp. 998- 1006 ,(2000) , 10.1056/NEJM200004063421402
Björn Hackanson, Kristi L. Bennett, Romulo M. Brena, Jinmai Jiang, Rainer Claus, Shih-Shih Chen, Nadya Blagitko-Dorfs, Katie Maharry, Susan P. Whitman, Thomas D. Schmittgen, Michael Lübbert, Guido Marcucci, Clara D. Bloomfield, Christoph Plass, Epigenetic Modification of CCAAT/Enhancer Binding Protein α Expression in Acute Myeloid Leukemia Cancer Research. ,vol. 68, pp. 3142- 3151 ,(2008) , 10.1158/0008-5472.CAN-08-0483
GJL Kaspers, AJP Veerman, R Pieters, GJ Broekema, DR Huismans, KM Kazemier, AH Loonen, MAA Rottier, CH van Zantwijk, K Hählen, Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay British Journal of Cancer. ,vol. 70, pp. 1047- 1052 ,(1994) , 10.1038/BJC.1994.446
Jules P.P. Meijerink, Monique L. den Boer, Rob Pieters, New Genetic Abnormalities and Treatment Response in Acute Lymphoblastic Leukemia Seminars in Hematology. ,vol. 46, pp. 16- 23 ,(2009) , 10.1053/J.SEMINHEMATOL.2008.09.006